Evaluation of outpatient adverse drug reactions leading to hospitalization

American Journal of Health-System Pharmacy

Volumn 60, Issue 3, 2003, Pages 253-259

  Wu, Wenchen Kenneth ^a   Pantaleo, Nicholas ^b  

^a ST JOHN'S UNIVERSITY   (United States)

^b JAMAICA HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Anticoagulants; Anticonvulsants; Antidiabetic agents; Costs; Drugs, adverse reactions; Geriatrics; Hospitals; Patients; Sympatholytic agents

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARDIAC GLYCOSIDE; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLIPIZIDE; IBUPROFEN; INSULIN; LISINOPRIL; METOPROLOL; PHENYTOIN; WARFARIN; DRUG;

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; EMERGENCY WARD; EVALUATION; FEMALE; GERIATRICS; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT CARE; PRIORITY JOURNAL; SIDE EFFECT; TEACHING HOSPITAL; AGE; COMPARATIVE STUDY; DRUG SURVEILLANCE PROGRAM; ECONOMICS; HOSPITAL ADMISSION; MIDDLE AGED; STATISTICS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT ADMISSION; PHARMACEUTICAL PREPARATIONS;

EID: 0012893149     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.3.253     Document Type: Article

References (23)

1. Grymonpre RE, Mitenko PA, Sitar DS et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc. 1988; 36:1092-8.
2. Ives TJ, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Arch Intern Med. 1987; 147:1117-20.
3. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990; 150: 841-5.
4. Requirements for adverse reaction reporting. Geneva, Switzerland: World Health Organization; 1975.
5. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. JAMA. 1995; 274:29-34.
6. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. JAMA. 1995; 274:35-43.
7. Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-11.
8. Classen DC, Pestotnik SI, Evans RS et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997; 277:301-6.
9. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health-Syst Pharm. 1996; 53:1422-6.
10. Suh DC, Woodall BS, Shin SK et al. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother. 2000; 34:1373-9.
11. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279: 1200-5.
12. Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993; 27: 832-40.
13. Prince BS, Goetz CM, Rihn TL et al. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm. 1992; 49:1696-700.
14. Miller RR. Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med. 1974; 134: 219-23.
15. Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc. 1989; 37:323-6.
16. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse reactions and related resource use. A study of community-dwelling persons 65 years of age and older. Ann Intern Med. 1992; 117:634-40.
17. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost of illness model. Arch Intern Med. 1995; 155:194-956.
18. Tafreshi MJ, Melby MJ, Kaback KR et al. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother. 1999; 33:1252-7.
19. Aparasu RR, Helgeland DL. Utilization of ambulatory care services caused by adverse effects of medications in the United States. Manag Care Interface. 2000; 13:70-5.
20. Levy M, Lipshitz M, Eliakim M. Hospital admissions due to adverse drug reactions. Am J Med Sci. 1979; 277:49-56.
21. Beers MH, Berkow R, eds. Merck manual of diagnosis and therapy. Whitehouse Station, NJ: Merck & Co.; 1999.
22. Henkel J. MedWatch. FDA's 'heads up' on medical product safety. FDA Consum. 1998; 32:10-5.
23. Pouyanne P, Haramburu F, Imbs JL et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ. 2000; 320:1036.